A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.
Ahmed J, Stephen B, Khawaja MR, Yang Y, Salih I, Barrientos-Toro E, Raso MG, Karp DD, Piha-Paul SA, Sood AK, Ng CS, Johnson A, Soliman PT, Meric-Bernstam F, Lu KH, Naing A.
Ahmed J, et al. Among authors: sood ak.
Gynecol Oncol. 2025 Jan 8;193:73-80. doi: 10.1016/j.ygyno.2024.12.019. Online ahead of print.
Gynecol Oncol. 2025.
PMID: 39787747